« Back
Home /
Atezolizumab (anti-PD-L1)

Atezolizumab (anti-PD-L1)

Manufacturer	Selleckchem
Category	Oncology Antibodies By Cell Type Blastoma Carcinoma Glioma Hematology Lymphoma Melanoma Sarcoma Mesothelioma Primary Antibodies
Type	Antibody
Specific against	other
Amount	1 mg x 5
Item no.	A2004-5
Targets	CD274
CASRN	1380723-44-3
eClass 6.1	32160702
eClass 9.0	32160702
Available
Information	Atezolizumab (anti-PD-L1) is a fully humanized, IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1, but not the interaction of PD-L2 with PD-1. MW : 145 KD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg x 5

available

Delivery expected until 5/16/2024